172 related articles for article (PubMed ID: 15904905)
1. Significance and role of early-lesions in experimental colorectal carcinogenesis.
Mori H; Hata K; Yamada Y; Kuno T; Hara A
Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
[TBL] [Abstract][Full Text] [Related]
2. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
3. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
Yamada Y; Mori H
Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
[TBL] [Abstract][Full Text] [Related]
4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
7. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin expression is altered in human colonic aberrant crypt foci.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
[TBL] [Abstract][Full Text] [Related]
9. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.
Femia AP; Dolara P; Giannini A; Salvadori M; Biggeri A; Caderni G
Cancer Res; 2007 Jan; 67(2):445-9. PubMed ID: 17234750
[TBL] [Abstract][Full Text] [Related]
10. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
12. Identification of mucin depleted foci in the human colon.
Femia AP; Giannini A; Fazi M; Tarquini E; Salvadori M; Roncucci L; Tonelli F; Dolara P; Caderni G
Cancer Prev Res (Phila); 2008 Dec; 1(7):562-7. PubMed ID: 19139006
[TBL] [Abstract][Full Text] [Related]
13. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
Hirose Y; Kuno T; Yamada Y; Sakata K; Katayama M; Yoshida K; Qiao Z; Hata K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):107-11. PubMed ID: 12538355
[TBL] [Abstract][Full Text] [Related]
14. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
[TBL] [Abstract][Full Text] [Related]
15. Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
Pretlow TP; Bird RP
Cancer Res; 2001 Oct; 61(20):7699-701. PubMed ID: 11606415
[No Abstract] [Full Text] [Related]
16. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
Femia AP; Bendinelli B; Giannini A; Salvadori M; Pinzani P; Dolara P; Caderni G
Int J Cancer; 2005 Aug; 116(1):9-15. PubMed ID: 15751047
[TBL] [Abstract][Full Text] [Related]
17. Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma.
Roncucci L
Ital J Gastroenterol; 1992; 24(9):498-501. PubMed ID: 1489980
[TBL] [Abstract][Full Text] [Related]
18. Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride.
Yoshimi N; Morioka T; Kinjo T; Inamine M; Kaneshiro T; Shimizu T; Suzui M; Yamada Y; Mori H
Cancer Sci; 2004 Oct; 95(10):792-7. PubMed ID: 15504245
[TBL] [Abstract][Full Text] [Related]
19. A new medium-term rat colorectal bioassay applying neoplastic lesions as end points for detection of carcinogenesis modifiers effects with weak or controversial modifiers.
Cho YM; Imai T; Ota Y; Hasumura M; Takami S; Hirose M; Nishikawa A
Toxicol Pathol; 2008 Apr; 36(3):459-64. PubMed ID: 18349425
[TBL] [Abstract][Full Text] [Related]
20. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.
Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K
Carcinogenesis; 2005 Jan; 26(1):229-38. PubMed ID: 15459021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]